RxDoctor Payments Data

Melanie Santiago

Medical · Fort Myers, FLNPI 1326519117

Payments from drug & device makers

$1,985in general payments, 2019–2025

Across 110 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$329
  • Amgen$300
  • Novo Nordisk$281
  • AbbVie$278
  • Boehringer Ingelheim$241
  • Exact Sciences$142
  • plus $415 from 9 others

What the payments were for

  • Food & beverage$1,985100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,985 in reported general payments places this provider in the 70th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$13,969
Medicare patients
76
Services billed
370

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban62$81,777
OzempicSemaglutide38$49,163
JardianceEmpagliflozin33$39,593
TrulicityDulaglutide16$28,431
MounjaroTirzepatide12$18,183
Breo ElliptaFluticasone/Vilanterol11$7,895
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$5,532
Levothyroxine Sodium210$3,796
Metoprolol Succinate167$3,791
Rosuvastatin Calcium204$3,578
Atorvastatin Calcium210$3,053
SymbicortBudesonide/Formoterol Fumarate13$3,044
SynthroidLevothyroxine Sodium45$2,914
Lisinopril218$2,758
Irbesartan68$2,436

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$55$81,77762 claims
Novo NordiskOzempic$281$49,16338 claims
Lilly USA, LLCTrulicity, Mounjaro$329$46,61428 claims
Boehringer IngelheimJardiance$241$39,59333 claims
GSKBreo Ellipta$60$7,89511 claims
AstraZenecaSymbicort$66$3,04413 claims
AbbVieSynthroid$278$2,91445 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,031 medical providers in Florida.

Other medical in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →